drugset / Trial / NCT00251602

Analysis of Atropine and Propranolol Induced Changes

NCT00251602

Phase 1 Completed 24 enrolled National Institute on Aging (NIA)
RandomizedCrossoverOpen-labelDiagnostic

Summary

The purpose of this study is to learn the effects of genetic make up on response to the drugs atropine and propranolol, to examine how changes in heart rate and blood pressure can be measured, and to test a new statistical analysis method.

Timeline

Start
2003-03
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 10 ug/kg Other
Subject Propranolol Small molecule 0.8 mg/kg Other

Indications

No indication recorded.